Abstract: Compounds of the formula ##STR1## and processes for and intermediates in the synthesis thereof, pharmaceutical compositions comprising such a compound and the use of such compounds for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis.

Abstract: Complexes of the formula ##STR1## wherein each R.sub.1 is independently (a) the radical of a coupling component of the active methylene non-cyclic or homocyclic series, (b) the radical of a coupling component of the heterocyclic series or (c) the radical of a coupling component of the monocyclic benzene series,with the proviso that at least one R.sub.1 is the radical of a coupling component of the active methylene non-cyclic or homocyclic series,each R.sub.2 is independently hydrogen, C.sub.1-4 alkyl or --SO.sub.2 NR.sub.4 R.sub.5,each R.sub.3 is independently hydrogen, halo, C.sub.1-4 alkyl or --SO.sub.2 NR.sub.4 R.sub.5, andeach M and M.sub.1 is independently hydrogen or a cation,wherein each R.sub.4 is independently hydrogen, C.sub.1-4 alkyl or C.sub.2-3 hydroxyalkyl, andeach R.sub.5 is independently hydrogen, C.sub.1-4 alkyl, C.sub.2-3 hydroxyalkyl, cyclohexyl, cyclohexyl substituted by methyl, phenyl or phenyl substituted by methyl, with the proviso that at least one of Ring A and R.sub.

Abstract: Complexes of the formula ##STR1## and salts thereof each cation of which is independently a non-chromophoric cation,wherein B is --CO--CH.dbd.CH--CO--, --CO--(CH.sub.2).sub.a --CO--, ##STR2## and each of R.sub.1, R.sub.2, R.sub.3 and R.sub.4 is independently hydrogen, halo, nitro, C.sub.1-4 alkyl, C.sub.1-4 alkyoxy, --NHCO--R.sub.6, --CO--R.sub.7 or --SO.sub.2 --R.sub.8,wherein R.sub.6 is C.sub.1-4 alkyl or phenyl,R.sub.7 is hydroxy; --OR.sub.9 ; C.sub.1-4 alkyl; phenyl; phenyl substituted by 1 or 2 substituents selected from halo, nitro, C.sub.1-4 alkyl and C.sub.1-4 alkoxy; cyclohexyl; cyclohexyl substituted by 1 to 3 C.sub.1-4 alkyl groups; or --NR.sub.10 R.sub.11, and,R.sub.8 is hydroxy; C.sub.1-4 alkyl; C.sub.1-4 alkyl monosubstituted by halo or sulfato; C.sub.2-4 alkenyl; phenyl; phenyl substituted by 1 or 2 substituents selected from halo, nitro, C.sub.1-4 alkyl and C.sub.1-4 alkoxy; cyclohexyl; cyclohexyl substituted by 1 to 3 C.sub.1-4 alkyl groups; or --NR.sub.10 R.sub.

Abstract: Metal-free monoazo and disazo compounds of the formulaCH.sub.2 .dbd.CH--SO.sub.2 --W.sub.1 --D--N.dbd.N--K--(W.sub.2 --Z).sub.n,1:1 and 1:2 metal complexes of such metallizable metal-free compounds and acid addition salts of such metal-free compounds and 1:1 and 1:2 metal complexes, whereinD is the radical of a diazo component of the benzene, naphthalene or tetrahydronaphthalene series,K is the radical of a coupling component of the benzene, naphthalene, pyrazol-5-one, pyridine, pyridone, barbituric acid, quinoline, isoquinoline, benzeneazobenzene, benzeneazonaphthalene, naphthaleneazobenzene, naphthaleneazonaphthalene, tetrahydronaphthaleneazobenzene, tetrahydronaphthaleneazonaphthalene or acetoacetamide series,W.sub.1 is a direct bond or a divalent bridging radical,each W.sub.

Abstract: Compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein the various substituents are defined hereinbelow and the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis, pharmaceutical compositions comprising such compounds and processes for and intermediates in the synthesis of such compounds.

Abstract: The invention provides compounds of formula I ##STR1## wherein R is C.sub.1-4 alkoxy-C.sub.2-4 alkyl of which the C.sub.1-4 alkoxy group is separated by at least 2 C-atoms from the N-atom to which R is bound,each of R.sub.2 and R.sub.4 independently is CH.sub.3 or C.sub.2 H.sub.5 andR.sub.5 is H or CH.sub.3,the preparation of such compounds and the use of such compounds for the preparation of N-(thien-3-yl)-chloroacetamides.

Abstract: Compounds of the formula ##STR1## wherein R.sub.1 is C.sub.1-3 alkyl, andZ is ##STR2## wherein R.sub.7 is hydrogen, R.sub.8 or M,whereinR.sub.8 is a physiologically acceptable and hydrolyzable ester group, andM is a pharmaceutically acceptable cation,the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis, pharmaceutical compositions comprising such compounds and processes for and intermediates in the synthesis of such compounds.

Abstract: A composition comprising:(a) 30 to 90% by weight of one or more water soluble anionic dyestuffs in metal complex form,(b) 0.5 to 20% by weight of one or more compounds of formula I ##STR1## in which R.sub.1 is C.sub.12-22 alkyl or C.sub.12-22 alkenyl; R.sub.2 is hydrogen or --SO.sub.3 M;m is 2, 3 or 4;n is 2, 3 or 4;p+p' is 10 to 30 inclusive, each of p and p' being at least 1; and M is a cation; and(c) 5 to 40% by weight of a dispersing agent.These compositions are suitable for dyeing of textile and leather substrates.

Abstract: Polyester-cotton blend textile substrates are dyed with a disperse dye and then with a sulfur dye from the same dyebath which is maintained at a temperature no higher than 105.degree. C. when the sulfur dye is present therein and which preferably contains glucose as the reducing agent for the sulfur dye.

Abstract: Leather, hides, skins or fur-skins are treated before and/or during dyeing with basic dyes, with a compound of formula I ##STR1## in which R.sub.1 is a C.sub.8-18 aliphatic residue;each R.sub.2, independently, is C.sub.1-4 alkyl;R.sub.3 is a C.sub.1-18 aliphatic residue or --CH.sub.2 -R.sub.4 where R.sub.4 is phenyl; phenyl substituted by up to two substituents selected from the group consisting of chlorine, bromine, methyl, methoxy and ethoxy; or naphthyl; andX is an anion,or a mixture thereof. Dyeings with improved levelness and reproducibility are thus obtained.

Abstract: The invention provides hybrid microorganisms comprising the gene coding for b.t. kurstaki delta-endotoxin and the gene coding for b.t. tenebrionis delta-endotoxin, their preparation, insecticidal compositions comprising such microorganisms and their use.

Abstract: A solvent-free oil-in-water emulsion of propetamphos comprising(a) 5 to 50% by weight of technical propetamphos in the form of droplets having a particle size of below 5 micron,(b) 1 to 8% by weight of a polyvinyl alcohol,(c) 1 to 3% by weight of a buffer, buffering the pH of the formulation to pH 6 to 7,(d) 1 to 2% by weight of a vegetable oil,(e) 0.5 to 2% by weight of an emulsifier(f) 0 to 8% by weight of an antifreezing agent(g) 0 to 0.1% by weight of an antifoaming agent (h) 0 to 0.1% by weight of a perfume,the balance being water, and a process of preparing such emulsion.

Abstract: Mixtures comprising at least two dyes of formula I ##STR1## where R is unsubstituted linear C.sub.3-7 alkyl, with the proviso that at least two different dyes of formula I are each present to the extent of at least 10 mole %, based on the total molar quantity of dyes present, which are useful for dyeing and printing synthetic and semi-synthetic high molecular weight, hydrophobic organic substrates, particularly for rapid dyeing.

Abstract: The invention provides a method of combatting fungal diseases with the aid of(a) the compound of formula I ##STR1## and (b) the compound of formula II ##STR2## and fungicidal compositions comprising said compounds.

Abstract: Metal-free compounds of the formula ##STR1## 1:1 and 1:2 metal complexes thereof, and acid addition salts of metal-free compounds of said formula and 1:1 and 1:2 metal complexes thereof, whereinB is hydrogen; C.sub.1-4 alkyl; C.sub.1-4 alkyl monosubstituted by C.sub.1-4 alkoxy; C.sub.2-4 alkyl substituted by hydroxy; C.sub.5-6 cycloalkyl; C.sub.5-6 cycloalkyl substituted by 1 to 3 C.sub.1-4 alkyl groups; phenyl(C.sub.1-3 alkyl); phenyl(C.sub.1-3 alkyl) the phenyl group of which is substituted by 1 to 3 substituents selected from C.sub.1-4 alkyl, C.sub.1-4 alkoxy and halo; --A--NH--R.sub.2 ; --A'.sub.4 --N(R.sub.7).sub.2 ; --A.sub.4 --N.sup..sym. (R.sub.8).sub.2 R.sub.9 A.sup..crclbar. or --N(R.sub.7).sub.2,R is hydrogen; C.sub.1-4 alkyl; C.sub.5-6 cycloalkyl; C.sub.5-6 cycloalkyl substituted by 1 or 2 C.sub.

Abstract: An aqueous dispersion comprising one or more 2,2,6,6-tetraalkylpiperidine compounds having a molecular weight 2000 or less than 2000 and a melting point of 100.degree. C. or more, one or more cationic, non-ionic and/or anionic dispersing agents and an aqueous medium. These dispersions are suitable for use as light stabilizers in aqueous systems.

Abstract: A water soluble or water dispersible composition containing(a) at least one phosphoric acid partial ester(b.sub.1) at least one mono- or di-(C.sub.2-3 alkylene) glycol mono-(C.sub.1-4 -alkyl) ether or at least one aliphatic C.sub.4-6 alcohol or a mixture thereof(b.sub.2) mono- or diethylene glycol or a mixture thereof(c) at least one aromatic-free or aromatic-poor hydrocarbon oil, and(d) a water miscible alkanolamine,the phosphoric acid partial ester (a) being dispersed or dissolved in the mixture (b.sub.1)+(b.sub.2)+(c), and component (a) being at least partially neutralized in salt form, with the proviso that the composition has a water content .ltoreq.5% by weight.It is useful as fatting agent for fatting leather.

Abstract: A liquid concentrate comprising an oxamide and a 2,2,6,6-tetraalkylpiperidine compound dissolved in an organic solvent is useful for the UV-stabilization of hardenable liquid finishes, particularly automotive finishes.

Abstract: A method of fatting tanned leather substrates comprising(a) applying to the substrate as the fatting agent an aqueous solution or dispersion of an ortho-phosphoric acid partial ester having attached to the phosphorus atom an average 1 to 2 (which may be a non-integral number) groups of the formula I ##STR1## where each A independently is ##STR2## and n is a number from 2 to 10 with the proviso that 2 to 6 groups A are --(CH.sub.2).sub.2,R is an unsubstituted linear or branched (preferably linear) C.sub.14-20 alkyl group or an unsubstituted linear or branched (preferably linear) C.sub.14-20 alkenyl group,the phosphoric acid partial ester being in free acid or salt form;(b) treating with an agent selected from polyvalent metal oxide, hydroxide and salt, at the same time as fatting or after fatting.

Abstract: The subject matter of this invention involves 2-[4-(2-pyridinyloxy)phenoxy]propionyl-2-oxazolidinones which are substituted in the pyridinyl ring by trifluoromethyl and/or chloro. The compounds are useful for increasing the recoverable sugar in sugarcane.